Work

Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?

Year: 2018

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-018-0055-6

Authors: Alan Ashworth, Christopher J. Lord

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Institute of Cancer Research, Breast Cancer Now, Cancer Research UK

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Research UK

Awards: G2368474871, G5776296855, G6459970996

OpenAlex ID: W2810280645

FWCI: 5.828

Cites: 137

Cited by: 436

Related to: 10